Sanofi Said to Plan Move Out of Paris Headquarters to Cut Costs

  • Company said to discuss leaving rented site on rue La Boetie
  • Legal setback on cholesterol drug adds to pressure on expenses

Sanofi, France’s biggest drugmaker, is discussing a move out of its headquarters in central Paris as part of Chief Executive Officer Olivier Brandicourt’s push to save money, according to people familiar with the situation.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.